SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3376don't know. i don't have access to their research, just their rec's bob zagorin-1/23/2003
3375Bob Is Needham short-term oriented with their recommendations or long-term. MJ-1/23/2003
3374i don't discount the possibility of hanky panky but i also think isis has bebob zagorin-1/23/2003
3373News item: Isis Trades Spark Speculation By Steven Smith Staff Reporter 01/22/The Band Leader-1/23/2003
3372CARLSBAD, Calif., Jan. 22 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (nigel bates-1/22/2003
3371Yes, this is good news. It would be nice to know the terms of the agreement, buMr. Sunshine-1/16/2003
3370News this morning. I like how they prominently mention shareholder value. PresThe Band Leader-1/16/2003
3369ISIS is the only green thing on my screen. Anyone know what's up? I could Mr. Sunshine-1/15/2003
3368Seems like failure of the trial has been priced in, but results aren't in yeThe Band Leader-1/10/2003
3367fwiw, needham has reiterated its strong buy on isis at end of last week. so theybob zagorin-1/6/2003
3366actually his biotech people are pretty good imo although he's had a terriblebob zagorin-1/3/2003
3365Mike Murphy rarely has a clue. MIKEMichael Young-1/3/2003
3364fwiw today, CTSL (Mike Murphy) is predicting approval for affinitac "...we bob zagorin-1/3/2003
3363I think he is great. He has good sources in the biotech hedge fund community. Michael Young-1/2/2003
3362Suit yourself. I've found him useful, and much improved over time. I often stom pope-12/31/2002
3361feuerstein is a jerk. yes, he was right on price and his stories helped the shorbob zagorin-12/31/2002
3360<i>He bashed about every mid-tier in the book. ITMN, GNTA, ISIS, and many tom pope-12/31/2002
3359"Let's just forget about 2002, shall we?", Adam says. What you meaElmer-12/31/2002
3358Adam Feuerstein Biotech Looks Past Its Latest Annus Horribilis By Adam Feuersteibob zagorin-12/31/2002
3357PK/PD study of 2302's successors: jpet.aspetjournals.org Should lead to eatuck-12/30/2002
3356Hot off the press, an interesting article from the GeneTrove division, concernintuck-12/30/2002
3355No message.keokalani'nui-12/23/2002
3354>>CARLSBAD, Calif., Dec. 23 /PRNewswire-FirstCall/ -- Isis Pharmaceuticalstuck-12/23/2002
3353Isis Pharmaceuticals Reports New Data From Phase II Clinical Trial Of ISIS 2503 bob zagorin-12/20/2002
3352today ISIS Pharm ISIS Rodman & Renshaw Mkt Outperform $15bob zagorin-12/18/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News